BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mamdouhi T, Twomey JD, McSweeney KM, Zhang B. Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases. Cancer Metastasis Rev 2019;38:297-305. [PMID: 31053984 DOI: 10.1007/s10555-019-09795-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao X, Qi Z, Gao Z, He H. High counting of circulating tumor cells in blood is not directly related to metastasis. Cytometry A 2022. [PMID: 35912963 DOI: 10.1002/cyto.a.24672] [Reference Citation Analysis]
2 Kapeleris J, Ebrahimi Warkiani M, Kulasinghe A, Vela I, Kenny L, Ladwa R, O'Byrne K, Punyadeera C. Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer-An Update. Front Oncol 2022;12:859152. [PMID: 35372000 DOI: 10.3389/fonc.2022.859152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 廖 亮. Application of Circulating Tumor Cells in Colorectal Cancer. ACM 2022;12:1629-16533. [DOI: 10.12677/acm.2022.123234] [Reference Citation Analysis]
4 Liu Y, Lyu N, Rodger A, Wang Y. Surface-enhanced Raman spectroscopy for circulating biomarkers detection in clinical diagnosis. Principles and Clinical Diagnostic Applications of Surface-Enhanced Raman Spectroscopy 2022. [DOI: 10.1016/b978-0-12-821121-2.00008-1] [Reference Citation Analysis]
5 Tieng FYF, Abu N, Nasir SN, Lee LH, Ab Mutalib NS. Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells. Diagnostics (Basel) 2021;11:2136. [PMID: 34829483 DOI: 10.3390/diagnostics11112136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li C, Feng X, Yang S, Xu H, Yin X, Yu Y. Capture, Detection, and Simultaneous Identification of Rare Circulating Tumor Cells Based on a Rhodamine 6G-Loaded Metal-Organic Framework. ACS Appl Mater Interfaces 2021. [PMID: 34709779 DOI: 10.1021/acsami.1c15838] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
7 Abdallah EA, Souza E Silva V, Braun AC, Gasparini VA, Kupper BEC, Tariki MS, Tarazona JGR, Takahashi RM, Aguiar Júnior S, Chinen LTD. A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer. Transl Oncol 2021;14:100932. [PMID: 33157516 DOI: 10.1016/j.tranon.2020.100932] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 . Metastasis: A Bane of Breast Cancer Therapy. EMJ. [DOI: 10.33590/emj/20-00039] [Reference Citation Analysis]
9 Vacante M, Ciuni R, Basile F, Biondi A. The Liquid Biopsy in the Management of Colorectal Cancer: An Overview. Biomedicines. 2020;8. [PMID: 32858879 DOI: 10.3390/biomedicines8090308] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
10 Serwer P, T. Wright E, B. Gonzales C. Phage Capsids as Gated, Long-Persistence, Uniform Drug Delivery Vehicles. Current and Future Aspects of Nanomedicine 2020. [DOI: 10.5772/intechopen.91052] [Reference Citation Analysis]
11 Mentis AA, Grivas PD, Dardiotis E, Romas NA, Papavassiliou AG. Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal. Cell Mol Life Sci 2020;77:3671-90. [PMID: 32333084 DOI: 10.1007/s00018-020-03529-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 de Kruijff IE, Beije N, Martens JWM, de Wit R, Boormans JL, Sleijfer S. Liquid Biopsies to Select Patients for Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: A Systematic Review. Eur Urol Oncol 2021;4:204-14. [PMID: 32059957 DOI: 10.1016/j.euo.2020.01.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Wang J, Koo KM, Wang Y, Trau M. Engineering State-of-the-Art Plasmonic Nanomaterials for SERS-Based Clinical Liquid Biopsy Applications. Adv Sci (Weinh) 2019;6:1900730. [PMID: 31832306 DOI: 10.1002/advs.201900730] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 22.3] [Reference Citation Analysis]
14 Garrido-Navas C, de Miguel-Perez D, Exposito-Hernandez J, Bayarri C, Amezcua V, Ortigosa A, Valdivia J, Guerrero R, Garcia Puche JL, Lorente JA, Serrano MJ. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents. Cells 2019;8:E1382. [PMID: 31684193 DOI: 10.3390/cells8111382] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
15 Yurkovich JT, Tian Q, Price ND, Hood L. A systems approach to clinical oncology uses deep phenotyping to deliver personalized care. Nat Rev Clin Oncol 2020;17:183-94. [DOI: 10.1038/s41571-019-0273-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
16 Rao L, Luo L, Luo L, Chen S, Ran R, Liu X. Identification of plasma exosomes long non-coding RNA HAGLR and circulating tumor cells as potential prognosis biomarkers in non-small cell lung cancer. Transl Cancer Res 2019;8:2264-73. [PMID: 35116979 DOI: 10.21037/tcr.2019.09.43] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]